Cognitive Behavioral Therapy for Leukemia and Lymphoma-related Fatigue
Trial Summary
What is the purpose of this trial?
This trial studies how well cognitive behavioral therapy (CBT) works in helping patients with acute myeloid leukemia or lymphoma manage cancer-related fatigue. CBT involves talking with a therapist to change thinking and behavior patterns, which can help reduce fatigue and improve emotional well-being. CBT has been shown to be effective in reducing fatigue and improving emotional well-being in various conditions, including chronic fatigue syndrome and cancer-related fatigue.
Research Team
Sriram Yennu
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for patients with acute myeloid leukemia or lymphoma who are experiencing cancer-related fatigue. They must have a performance status indicating they can carry out light activity, have had persistent fatigue for at least two weeks, and not be severely anemic. Participants should speak English or Spanish and haven't received cognitive behavioral therapy in the past year.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Cognitive Behavior Therapy (Behavioural Intervention)
Cognitive Behavior Therapy is already approved in Canada for the following indications:
- Chronic pain management
- Anxiety disorders
- Depressive disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School